Detecting Rejection without Biopsies: Are we there yet?

 

When:
Presented on Tuesday, January 22, 2019

Continuing education credits available until:
Wednesday, January 22, 2020

Moderator/Speakers:

Linda Ohler MSN, RN, CCTC, FAAN, FAST - Moderator
Associate Director, Transplant Quality & Regulatory 
New York University Langone Health
New York, NY
Daniel C Brennan, MD, FACP - Speaker
Professor of Medicine, Division of Nephrology; Medical Director, The Comprehensive Transplant Center
Johns Hopkins University School of Medicine
Baltimore, MD
Jeff Teuteberg, MD - Speaker
Associate Professor of Cardiovascular Medicine; Section Chief, Heart Failure, Cardiac Transplantation, Mechanical Circulatory Support, Cardiovascular Medicine
The Stanford University Medical Center
Stanford, CA 


 

Purpose/Goal:
For many years, the Gold Standard for detecting rejection in transplant recipients of solid organs has been a tissue biopsy of the transplanted organ. Given that this is an invasive procedure, there are significant associated risks to the organ and the recipient patient. The search for another reliable method of detecting rejection has been ongoing for many years. Recent advances in the field provide promise that blood tests using DNA technology may finally result in a reliable alternative to traditional biopsies. During this webinar, two clinical experts, one in kidney transplantation and one in heart transplantation, present scientific and clinical data to support the use of this alternative technique.

Target Audience:
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.

Learning Objectives:
At the end of the webinar, participants should be able to:

  • Identify outcomes of DART and CARGO studies used to determine rejection through blood tests.
  • Evaluate reports on the validity of blood tests used to detect rejection following heart or kidney transplantation
  • Discuss contraindications for use of biomarkers to detect rejection.

 

Speaker Biographies

 

CE Information

OnDemand Recording - Available until 1/22/2020: Detecting Rejection without Biopsies: Are we there yet?

Register Now

  • Tuesday Jan 22 2019, 2:00 PM - 3:00 PM
UA-58501002-1